GD
Grandfield & Dodd Portfolio holdings
AUM
$1.71B
This Quarter Return
+5.07%
1 Year Return
+14.85%
3 Year Return
+57.47%
5 Year Return
+112%
10 Year Return
+284.72%
AUM
$691M
AUM Growth
+$691M
(+5%)
Cap. Flow
+$22.4M
Cap. Flow
% of AUM
3.25%
Top 10 Holdings %
Top 10 Hldgs %
30.46%
Holding
176
New
3
Increased
78
Reduced
44
Closed
8
Top Buys
| 1 |
Hormel Foods
HRL
|
$15.6M |
| 2 |
Chubb
CB
|
$2.91M |
| 3 |
TWX
Time Warner Inc
TWX
|
$1.24M |
| 4 |
Novartis
NVS
|
$1.15M |
| 5 |
FedEx
FDX
|
$1.1M |
Top Sells
| 1 |
Williams Companies
WMB
|
$6.22M |
| 2 |
CB
CHUBB CORPORATION
CB
|
$5.12M |
| 3 |
Amgen
AMGN
|
$1.09M |
| 4 |
Vanguard Value ETF
VTV
|
$658K |
| 5 |
Vanguard Growth ETF
VUG
|
$584K |
Sector Composition
| 1 | Technology | 21.72% |
| 2 | Healthcare | 17.64% |
| 3 | Consumer Staples | 12.99% |
| 4 | Industrials | 10.45% |
| 5 | Energy | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Alphabet (Google) Class C
GOOG
$2.56T
| $591K | 0.09% |
793
+170
| +27% | +$127K |
|
102
Abbott
ABT
$229B
| $574K | 0.08% |
13,718
+899
| +7% | +$37.6K |
|
103
Eli Lilly
LLY
$659B
| $548K | 0.08% |
7,611
-126
| -2% | -$9.07K |
|
|
RDS.A
104
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $546K | 0.08% |
11,267
| – | – |
|
105
McDonald's
MCD
$225B
| $534K | 0.08% |
4,250
+1,004
| +31% | +$126K |
|
|
106
Alphabet (Google) Class A
GOOGL
$2.56T
| $516K | 0.07% |
677
+20
| +3% | +$15.2K |
|
107
H.B. Fuller
FUL
$3.24B
| $513K | 0.07% |
12,094
| – | – |
|
108
Intel
INTC
$106B
| $500K | 0.07% |
15,460
| – | – |
|
109
RTX Corp
RTX
$212B
| $490K | 0.07% |
4,897
-185
| -4% | -$18.5K |
|
110
Fiserv
FI
$74.4B
| $487K | 0.07% |
4,749
| – | – |
|
111
Sonoco
SON
$4.61B
| $469K | 0.07% |
9,666
| – | – |
|
112
Incyte
INCY
$16.8B
| $452K | 0.07% |
6,234
+1,860
| +43% | +$135K |
|
|
MDVN
113
DELISTED
MEDIVATION, INC.
MDVN
| $447K | 0.06% |
9,721
+3,800
| +64% | +$175K |
|
114
Target
TGT
$42B
| $439K | 0.06% |
5,336
-439
| -8% | -$36.1K |
|
115
Texas Instruments
TXN
$182B
| $429K | 0.06% |
7,466
+495
| +7% | +$28.4K |
|
116
Novo Nordisk
NVO
$251B
| $419K | 0.06% |
7,727
| – | – |
|
117
GSK
GSK
$78.5B
| $413K | 0.06% |
10,173
| – | – |
|
118
Campbell Soup
CPB
$9.38B
| $406K | 0.06% |
6,367
-50
| -0.8% | -$3.19K |
|
119
Regeneron Pharmaceuticals
REGN
$61.3B
| $406K | 0.06% |
1,127
+347
| +44% | +$125K |
|
120
Visa
V
$679B
| $405K | 0.06% |
5,292
| – | – |
|
|
APC
121
DELISTED
Anadarko Petroleum
APC
| $404K | 0.06% |
8,683
| – | – |
|
122
Biogen
BIIB
$20.5B
| $403K | 0.06% |
1,547
| – | – |
|
123
Intuitive Surgical
ISRG
$168B
| $403K | 0.06% |
671
-7
| -1% | -$4.2K |
|
124
Cisco
CSCO
$268B
| $399K | 0.06% |
14,002
+100
| +0.7% | +$2.85K |
|
125
BioMarin Pharmaceuticals
BMRN
$11.3B
| $384K | 0.06% |
4,659
+1,785
| +62% | +$147K |
|